Genome-wide association studies (GWAS) identified AD risk factors associated with microglial function such as TREM2, ApoE or CD33, highlighting their importance in disease pathogenesis [8, 35, 44, 63, 85, 92, 107]. Here, APOE is linked to Alzheimer disease.